Toll Free: 1-888-928-9744
Published: May, 2015 | Pages:
38 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Ironwood Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct's, 'Ironwood Pharmaceuticals, Inc. - Product Pipeline Review - 2015', provides an overview of the Ironwood Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Ironwood Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Ironwood Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Ironwood Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Ironwood Pharmaceuticals, Inc.'s pipeline products Reason to Buy - Evaluate Ironwood Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Ironwood Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Ironwood Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Ironwood Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Ironwood Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope - Explore the dormant and discontinued projects of Ironwood Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 4 Ironwood Pharmaceuticals, Inc. Snapshot 5 Ironwood Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Ironwood Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Ironwood Pharmaceuticals, Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Ironwood Pharmaceuticals, Inc. - Pipeline Products Glance 12 Ironwood Pharmaceuticals, Inc. - Late Stage Pipeline Products 12 Phase III Products/Combination Treatment Modalities 12 Ironwood Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 13 Phase II Products/Combination Treatment Modalities 13 Phase I Products/Combination Treatment Modalities 14 Ironwood Pharmaceuticals, Inc. - Early Stage Pipeline Products 15 Preclinical Products/Combination Treatment Modalities 15 Ironwood Pharmaceuticals, Inc. - Drug Profiles 16 linaclotide 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 IW-3718 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 IW-9179 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 IW-1973 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 IW-1701 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Ironwood Pharmaceuticals, Inc. - Pipeline Analysis 23 Ironwood Pharmaceuticals, Inc. - Pipeline Products by Target 23 Ironwood Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 24 Ironwood Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 25 Ironwood Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 26 Ironwood Pharmaceuticals, Inc. - Recent Pipeline Updates 27 Ironwood Pharmaceuticals, Inc. - Company Statement 32 Ironwood Pharmaceuticals, Inc. - Locations And Subsidiaries 36 Head Office 36 Other Locations & Subsidiaries 36 Appendix 37 Methodology 37 Coverage 37 Secondary Research 37 Primary Research 37 Expert Panel Validation 37 Contact Us 37 Disclaimer 38
List of Tables
Ironwood Pharmaceuticals, Inc., Key Information 5 Ironwood Pharmaceuticals, Inc., Key Facts 5 Ironwood Pharmaceuticals, Inc. - Pipeline by Indication, 2015 7 Ironwood Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8 Ironwood Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9 Ironwood Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2015 10 Ironwood Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2015 11 Ironwood Pharmaceuticals, Inc. - Phase III, 2015 12 Ironwood Pharmaceuticals, Inc. - Phase II, 2015 13 Ironwood Pharmaceuticals, Inc. - Phase I, 2015 14 Ironwood Pharmaceuticals, Inc. - Preclinical, 2015 15 Ironwood Pharmaceuticals, Inc. - Pipeline by Target, 2015 23 Ironwood Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 24 Ironwood Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 25 Ironwood Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 26 Ironwood Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 27 Ironwood Pharmaceuticals, Inc., Subsidiaries 36
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.